Kiwihiker,we never know what could happen, a great product will always get the big players involved.The product works, tested by the professionals, it is cheap, has a huge profit margin and there is demand. That's why it gets re-rated.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor